• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Pfizer

Pfizer Launches PfizerForAll: Connecting Patients to Care, Medications & Vaccinations

by Fred Pennic 08/27/2024 Leave a Comment

Pfizer Launches PfizerForAll: Connecting Patients to Care, Medications & Vaccinations

What You Should Know:  - Pharmaceutical giant Pfizer launches PfizerForAll, a user-friendly platform designed to simplify access to healthcare and wellness management for Americans.  - PfizerForAll addresses a common frustration: the difficulty of navigating the US healthcare system.  - A recent poll by the American Academy of Physician Associates found that 65% of Americans find managing their health overwhelming, and 73% feel the system fails to meet their needs.
Read More

Can Technology Live Up to Its Promise for Clinical Trials?

by Stephen Pyke, Chief Clinical Digital and Data Officer, Parexel 04/04/2023 Leave a Comment

Can Technology Live Up to Its Promise for Clinical Trials?

By creating efficiencies with technology, CROs have an opportunity to build clinical trials of the future. For many years, artificial intelligence (AI), machine learning (ML) and natural language processing (NLP) had a reputation in the biopharmaceutical industry as flashy buzzwords, with little concrete evidence to back up their promise. Over time, this lack of understanding has created drawn-out anticipation, leaving many skeptical about the true value of these tools.  As the
Read More

Tempus, Pfizer Partner to Advance Oncology Therapeutic Development

by Fred Pennic 02/28/2023 Leave a Comment

Tempus, Pfizer Partner to Advance Oncology Therapeutic Development

What You Should Know: - Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery and development in oncology. - Through this collaboration, Pfizer has access to Tempus’ AI-enabled platform and its library of de-identified, multimodal data to uncover insights that will power therapeutic development in oncology. -
Read More

Vysioneer & Pfizer Partner on AI-Powered Oncology Clinical Trials

by Jasmine Pennic 02/22/2023 Leave a Comment

Vysioneer & Pfizer Partner on AI-Powered Oncology Clinical Trials

What You Should Know: - Vysioneer, a provider of applied AI for Oncology, today announced a data-sharing agreement with Pfizer, a global leader in pharmaceuticals. The agreement aims to lay the foundation for the application of AI in oncology clinical trials. As part of the agreement, Vysioneer gains access to one of Pfizer's oncology clinical trial datasets to apply Vysioneer's advanced machine-learning techniques to facilitate the drug efficacy assessment process, thereby allowing Pfizer
Read More

39 Organizations Sign Global Heath Equity Pledge to Advance Health Equity Globally

by Fred Pennic 01/19/2023 Leave a Comment

39 Organizations Sign Global Heath Equity Pledge to Advance Health Equity Globally

What You Should Know: - Today, World Economic Forum announced that 39 organizations have signed the Global Health Equity Network Zero Health Gaps Pledge. - The pledge includes 10 key commitments all signatories have made to embed health equity principles throughout their operations, workforce and guiding philosophies. It marks the beginning of an historic journey to making health equity an integral part of business strategies globally and an important step towards a world without health
Read More

Why EHR Data Is Key to Gathering More Accurate Medical Assessments

by Jake Hochberg, Executive Director, Customer Insights at Arcadia 01/16/2023 Leave a Comment

Why EHR Data Is Key to Gathering More Accurate Medical Assessments

Patient data in electronic health records (EHRs) holds a wealth of insights that can enable health systems to better serve their patient populations.   However, data from EHRs is challenging because this data is messy due to the lack of standardization in how clinical data is collected, and often times valuable information is buried in unstructured fields such as notes. Additionally, EHR data is disconnected from EHR data at other sites of care resulting in an incomplete view of the
Read More

The Continuing Rise of AI in the Healthcare Sector in 2023

by Melissa Powell, COO of Genesis HealthCare 01/11/2023 Leave a Comment

The Continuing Rise of AI in the Healthcare Sector in 2023

The announcement in September 2022 that the health tech company Iodine Software was entering into a partnership with the software platform TruCode “to upend clinical administration using artificial intelligence” serves as one of the more recent reminders of AI’s considerable impact on the healthcare sector. Certainly, it will be felt not just in the administrative realm, but also in the clinical and operational aspects as well. And given the challenges presented by a rapidly aging population,
Read More

Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development

by Fred Pennic 12/15/2022 Leave a Comment

Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development

What You Should Know: - Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early identification of patients who may be at risk of cardiac amyloidosis. - Anumana will conduct a clinical validation trial and pursue De Novo classification for the algorithm as a
Read More

PointClickCare & Pfizer Launches Real World Data Collaboration

by Jasmine Pennic 11/08/2022 Leave a Comment

PointClickCare & Pfizer Launches Real World Data Collaboration

What You Should Know: - PointClickCare announced a collaboration with Pfizer Inc. to provide real-world insights for vulnerable populations at high risk of age-related disorders (including Cachexia) – further enhancing PCC’s mission to protect and support the senior population. - With coverage approaching 70% of the long-term and post-acute care (LTPAC) market, PointClickCare is uniquely positioned to provide life sciences companies, like Pfizer, with outcomes-based evidence through
Read More

Healthcare Companies on the Stock Market

by HITC Staff 08/10/2022 Leave a Comment

Good healthcare and the financial sector cannot be separated entirely, even when their base motivations lie in different directions. While the medical sector should focus more on the health of the patients instead of consumerism, a good amount of capital is needed to ensure a functional system. Naturally, we can find healthcare companies on the stock market. Considering the continuous need for health care, that is not tied to market crashes the way other stocks are, this is a great chance for
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |